Inclusion compound between beta cyclodextrin and praziquantel (PZQ) comprises an enhancer of the bioavailability of antiparasitic agent

NOVELTY – An inclusion compound between beta cyclodextrin and praziquantel (PZQ) has increase in the solubility of commercial PZQ and thus of the bioavailability of antiparasite agent. The controlled release of the drug impedes attainment of high plasmatic levels.

Main Application Field

C07 (Apparatus, formulation, general. including veterinary syringes, general formulations where the active compound is not central to the invention (e.g. wettable powders) and analysis.)

INVENTORS:

PAULA ENEIDA DE
LINO ANTONIO CARLOS SENGES
FRACETO LEONARDO FERNANDES
PINTO LUCIANA DE MATOS ALVES
JESUS MARCELO BISPO DE
TAKAHATA YUJI

54_ESQUISTOSSOMOSE

Patent number: BR200401621-A

PATENT STATUS:

For information contact Inova Unicamp

FOR ADDITIONAL INFORMATION:

parcerias@inova.unicamp.br

+55 (19) 3521-5207 / 2607